Biotech investors in China
Updated 16 Nov 2026
Venture funds
28 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Qiming Venture Partners Qiming Venture Partners invests in technology, consumer and healthcare companies at early and growth stages, with recent investments including Houmo.AI and AusperBio. Shanghai, China |
Health care, Artificial intelligence | Seed, Early stage venture, Late stage venture | 50% | 11 |
| 2 | Legend Capital Legend Capital invests in China, with recent investments including Infinigence and Sinsegye. Beijing, China |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 42% | 7 |
| 3 | BioVenture BioVenture offers early and growth stage investment, with recent investments including AusperBio and Degron Therapeutics. Suzhou, China |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 33% | 4 |
| 4 | K2VC K2VC invests in early stage technology startups, including Shexu Technology and Startorus Fusion. Beijing, China |
Commerce, Fintech | Seed, Early stage venture | 22% | 4 |
| 5 | Gaorong Capital Gaorong Capital focuses on TMT investments including AI and frontier technologies, including BioGeometry and Raysolve. Wangjing, China |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 29% | 3 |
| 6 | Haitang Fund Haitang Fund is a venture fund founded by Tianjin University alumni entrepreneurs, with recent investments in Zhonghe Gene and Xingsai Bio. Nankai, China |
Biotech, Health care | Early stage venture | 30% | 3 |
| 7 | IDG Capital IDG Capital funds early- to growth-stage technology companies, with recent investments including Zero Zero Robotics and XPENG Robotics. Beijing, China |
Hardware, Fintech | Seed, Early stage venture, Late stage venture | 36% | 3 |
| 8 | Matrix Partners China Matrix Partners China builds long-term relationships with entrepreneurs in China, with recent investments including Houmo.AI and Astribot. Beijing, China |
Artificial intelligence, Hardware | Early stage venture | 34% | 3 |
| 9 | Med-Fine Capital Med-Fine Capital focuses on healthcare and bio-science, with recent investments including Artivila Therapeutics and Phrontline Biopharma. Shanghai, China |
Health care, Biotech | Early stage venture | 30% | 3 |
| 10 | Shenzhen Capital Group Shenzhen Capital Group focuses on cultivating national industries and national brands, with recent investments including SAGE Intelligent and Chasing Innovation. Nanshan, China |
Hardware, Health care | Seed, Early stage venture, Late stage venture | 40% | 3 |
| 11 | Shunwei Capital Shunwei Capital focuses on China's internet industry at early to mid stages, with recent companies including SAGE Intelligent and Hooke Instruments. Beijing, China |
Hardware, Commerce | Seed, Early stage venture, Late stage venture | 31% | 3 |
| 12 | BioTrack Capital BioTrack Capital invests in life sciences, healthcare technology and biotechnology, with recent companies including Yuce Biotechnology and Rigen Biotech. Shanghai, China |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 33% | 2 |
| 13 | Boyuan Capital Boyuan Capital operates as an investment platform, with recent companies Yuce Biotechnology and Rigen Biotech. Shanghai, China |
Health care, Biotech | Late stage venture | 38% | 2 |
| 14 | Chengdu Science and Technology Venture Capital Chengdu Science and Technology Venture Capital is a venture firm with recent companies including Kunteng Tech, QL Biopharma and New Radiomedicine Technology. Chengdu, China |
Biotech, Health care | Early stage venture, Late stage venture | 36% | 2 |
| 15 | Fuho Capital Fuho Capital is an equity investment fund management company with recent investments in Novamab and Leman Biotech. Haidian, China |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 24% | 2 |
| 16 | Green Pine Capital Partners Green Pine Capital Partners is a venture firm whose recent companies include RealAI and MindRank AI. Shenzhen, China |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 32% | 2 |
| 17 | Kaitai Capital Kaitai Capital is a professional investment management organization, with recent companies including Xihu Xinchen and Bivision. Hangzhou, China |
Artificial intelligence, Biotech | Early stage venture | 30% | 2 |
| 18 | Lenovo Capital and Incubator Group (LCIG) Lenovo Capital and Incubator Group operates as an accelerator and venture firm, with recent investments including Elite Robots and Aibo Medical Robot. Beijing, China |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 24% | 2 |
| 19 | Linear Capital Linear Capital invests in data application projects, with recent companies SynMetaBio, Dishi Medical and ReaVis. Shanghai, China |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 31% | 2 |
| 20 | 5Y Capital 5Y Capital makes early-stage venture investments, with recent investments in Etern and CellCentric. Xuhui, China |
Artificial intelligence, Commerce | Seed, Early stage venture, Late stage venture | 31% | 2 |
| 21 | Northern Light Venture Capital Northern Light Venture Capital funds early- and growth-stage tech and consumer service companies, with recent investments including HemaCell and Picky. Beijing, China |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 24% | 2 |
| 22 | Oriza Holdings Oriza Holdings provides equity and debt financing to Chinese companies, with recent backings including Listenai and TuringQ. Suzhou, China |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 25% | 2 |
| 23 | SDIC Venture Capital SDIC Venture Capital manages four funds for semiconductor and pharmaceutical companies, including Bangxin Semiconductor and Ouye Semiconductor. Xicheng, China |
Hardware, Health care | Seed, Early stage venture, Late stage venture | 54% | 2 |
| 24 | Sherpa Healthcare Partners Sherpa Healthcare Partners focuses on pharmaceutical and biotech companies, with recent investments in MindRank AI and UniXell Biotechnology. Beijing, China |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 29% | 2 |
| 25 | SZHTI Group SZHTI Group provides asset management and financing services, including investments tied to Elegoo and SpinQ Technology. Shenzhen, China |
Hardware, Biotech | Early stage venture | 30% | 2 |
| 26 | Tiantu Capital Tiantu Capital is a venture capital association, with recent investments in Xellar Biosystems and Leman Biotech. Shenzhen, China |
Commerce, Artificial intelligence | Seed, Early stage venture | 52% | 2 |
| 27 | Wuxi Capital Wuxi Capital is a financial investment platform backing companies such as Kai Medtech and Sandstone. Wuxi Shi, China |
Hardware, Health care | Seed | 34% | 2 |
| 28 | Zhengxuan Investment Zhengxuan Investment invests in high-tech enterprises, with recent companies Yuce Biotechnology and Xellar Biosystems. Shenzhen, China |
Hardware, Artificial intelligence | Seed, Early stage venture | 49% | 2 |
Table 1. Biotech investors in China: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Qiming Venture Partners | Venture capital firm | Shanghai, China | •••@qimingvc.com | (+86) ••• |
| Legend Capital | Venture capital firm | Beijing, China | •••@legendcapital.com.cn | |
| Lilly Asia Ventures | Venture capital firm | Shanghai, China | •••@lillyasiaventures.com | +86 21••• |
| Matrix Partners China | Venture capital firm | Beijing, China | •••@matrixpartners.com.cn | +86-10••• |
| BioVenture | Venture capital firm | Suzhou, China | •••@bioventure.com.cn | +86512••• |
| Shenzhen Capital Group | Venture capital firm | Nanshan, China | •••@szvc.com.cn | 0755-8••• |
| Northern Light Venture Capital | Venture capital firm | Beijing, China | •••@nlightvc.com | 650-58••• |
| IDG Capital | Private equity firm | Beijing, China | •••@idgcapital.com | +86 10••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 86 of the 124 biotech investors in China have a published email address, 91 a phone number and 120 a website.
- Qiming Venture Partners has the most recorded investments, 1,106, 555 of them as lead investor.
- 112 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Lenovo Capital and Incubator Group (LCIG) is an investor in 27 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Huasaiboman Medical Cell Biology's $30.0M Series B on 9 November 2026.
- Software is the most common sector across their 2,652 portfolio companies (66%).
- Early stage venture is the most common investment stage, recorded for 118 of them (95%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in China
30 of 124, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Qiming Venture Partners | Venture capital firm | Shanghai, China | Health care, Artificial intelligence | Houmo.AI, Infinigence, AusperBio | 21 | 1,106 | 555 | 104 | •••@qimingvc.com | (+86) ••• | In the CSV |
| 2 | Legend Capital | Venture capital firm | Beijing, China | Artificial intelligence, Hardware | Infinigence, Sinsegye, Diyingjia Technology | 18 | 569 | 240 | 60 | •••@legendcapital.com.cn | In the CSV | |
| 3 | Lilly Asia Ventures | Venture capital firm | Shanghai, China | Health care, Biotech | Precede Biosciences, Akura Medical | 2 | 237 | 68 | 49 | •••@lillyasiaventures.com | +86 21••• | In the CSV |
| 4 | Matrix Partners China | Venture capital firm | Beijing, China | Artificial intelligence, Hardware | Houmo.AI, Astribot, SemiDrive | 14 | 793 | 271 | 59 | •••@matrixpartners.com.cn | +86-10••• | In the CSV |
| 5 | BioVenture | Venture capital firm | Suzhou, China | Health care, Biotech | AusperBio, Degron Therapeutics, AccuPulse | 5 | 182 | 60 | 13 | •••@bioventure.com.cn | +86512••• | |
| 6 | Kaitai Capital | Venture capital firm | Hangzhou, China | Artificial intelligence, Biotech | Xihu Xinchen, Bivision, Levinthal | 3 | 149 | 44 | 8 | +86 57••• | In the CSV | |
| 7 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | Hardware, Health care | SAGE Intelligent, Chasing Innovation, Kai Medtech | 16 | 794 | 316 | 102 | •••@szvc.com.cn | 0755-8••• | In the CSV |
| 8 | Northern Light Venture Capital | Venture capital firm | Beijing, China | Hardware, Artificial intelligence | Nutshell Therapeutics, HemaCell, Picky | 5 | 458 | 110 | 66 | •••@nlightvc.com | 650-58••• | In the CSV |
| 9 | Gaorong Capital | Venture capital firm | Wangjing, China | Artificial intelligence, Hardware | BioGeometry, Shexu Technology, Raysolve | 9 | 358 | 103 | 29 | 010-84••• | In the CSV | |
| 10 | IDG Capital | Private equity firm, Venture capital firm | Beijing, China | Hardware, Fintech | Zero Zero Robotics, XPENG Robotics, LaiHua | 13 | 1,565 | 567 | 183 | •••@idgcapital.com | +86 10••• | In the CSV |
| 11 | K2VC | Angel group, Venture capital firm | Beijing, China | Commerce, Fintech | Renshuo Solar, Shexu Technology, Aureka Biotechnologies | 9 | 337 | 73 | 9 | •••@k2vc.com | +86 10••• | In the CSV |
| 12 | Puhua Capital | Venture capital firm | Hangzhou, China | Hardware, Health care | Yuce Biotechnology, LaiHua, Garen Semiconductor | 6 | 269 | 88 | 14 | •••@puhuacapital.com | +571 8••• | In the CSV |
| 13 | 5Y Capital | Venture capital firm | Xuhui, China | Artificial intelligence, Commerce | Etern, CellCentric, BOTINKIT | 4 | 345 | 108 | 28 | +86 20••• | In the CSV | |
| 14 | Frees Fund | Venture capital firm | Beijing, China | Artificial intelligence, Hardware | Vibronix, Aeroband, Calterah | 5 | 233 | 63 | 12 | •••@freesvc.com | In the CSV | |
| 15 | BioTrack Capital | Venture capital firm | Shanghai, China | Health care, Biotech | Yuce Biotechnology, Shenluo Medical, Rigen Biotech | 3 | 85 | 28 | 5 | +86-02••• | ||
| 16 | Prox Ventures | Venture capital firm | Shanghai, China | Biotech, Health care | Leadinno Medical Valley | 1 | 71 | 14 | 1 | In the CSV | ||
| 17 | Shunwei Capital | Venture capital firm | Beijing, China | Hardware, Commerce | SAGE Intelligent, Hooke Instruments, Zongwei Automation | 12 | 607 | 188 | 46 | •••@shunwei.com | +86 (0••• | In the CSV |
| 18 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | Hardware, Artificial intelligence | Global Technology, Zhongke Ruijian, Xunjie Guangyuan | 15 | 366 | 140 | 47 | •••@fortunevc.com | In the CSV | |
| 19 | Source Code Capital | Venture capital firm | Chaoyang, China | Artificial intelligence, Hardware | FAIRINO, Nutshell Therapeutics, Raysolve | 10 | 356 | 113 | 19 | +86106••• | In the CSV | |
| 20 | Addor Capital | Venture capital firm | Nanjing, China | Hardware, Artificial intelligence | Zhizhen Precision, Micronano Core, Layerwave Bio | 8 | 350 | 173 | 26 | •••@addorcapital.com | 025-85••• | In the CSV |
| 21 | Oriental Fortune Capital | Venture capital firm | Shenzhen, China | Hardware, Artificial intelligence | Micronano Core, Renshuo Solar, EVAS Intelligence | 9 | 342 | 117 | 32 | •••@ofcapital.com | +86-75••• | In the CSV |
| 22 | CICC | Investment bank, Venture capital firm | Beijing, China | Hardware, Artificial intelligence | Global Technology, AIForceTech, Etern | 9 | 239 | 95 | 58 | •••@cicc.com.cn | (+86-1••• | In the CSV |
| 23 | Oriza Holdings | Venture capital firm | Suzhou, China | Hardware, Artificial intelligence | Mogulinker Technology, Muchuang, Listenai | 7 | 220 | 56 | 22 | •••@oriza.com.cn | In the CSV | |
| 24 | SDIC Venture Capital | Venture capital firm | Xicheng, China | Hardware, Health care | Bangxin Semiconductor, Shengqiang Technology, Weikaier Pharmaceutical Technology | 9 | 164 | 89 | 12 | •••@sdicvc.com | 010-63••• | In the CSV |
| 25 | Yinxinggu Capital | Venture capital firm | Hangzhou, China | Hardware, Artificial intelligence | Chasing Innovation, Lingshu Intelligent Technology, Mogulinker Technology | 8 | 161 | 18 | 7 | •••@yxgzb.com | + 0571••• | In the CSV |
| 26 | Huagai Capital | Private equity firm | Beijing, China | Hardware, Biotech | Utarn Technology, Bluesail Surgical, MindRank AI | 4 | 148 | 59 | 17 | •••@hgcapital.cn | +8610-••• | In the CSV |
| 27 | Sherpa Healthcare Partners | Venture capital firm | Beijing, China | Health care, Biotech | MindRank AI, UniXell Biotechnology | 2 | 99 | 29 | 10 | •••@sherpahp.com | 010 - ••• | In the CSV |
| 28 | New Alliance Capital | Private equity firm, Venture capital firm | Shanghai, China | Health care, Biotech | Degron Therapeutics | 1 | 96 | 9 | 10 | •••@nac-capital.com | 86-21-••• | In the CSV |
| 29 | Haiyuan Capital | Venture capital firm | Shenzhen, China | Health care, Biotech | Hongxin Biology | 1 | 70 | 40 | 3 | |||
| 30 | 3E Bioventures | Venture capital firm | Beijing, China | Biotech, Health care | Tianhu Technology | 1 | 62 | 21 | 10 | (810) ••• | In the CSV |
Table 2. Biotech investors in China: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 124.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Lenovo Capital and Incubator Group (LCIG) | Beijing, China | 27 | 99 | Micronano Core, Elite Robots, Aibo Medical Robot |
| 2 | Qiming Venture Partners | Shanghai, China | 21 | 154 | Houmo.AI, Infinigence, AusperBio |
| 3 | Legend Capital | Beijing, China | 18 | 103 | Infinigence, Sinsegye, Diyingjia Technology |
| 4 | CAS Star | Xian, China | 17 | 58 | Matrixtime Robotics, Renshuo Solar, YUSUR Technology |
| 5 | Shenzhen Capital Group | Nanshan, China | 16 | 166 | SAGE Intelligent, Chasing Innovation, Kai Medtech |
| 6 | Fortune Venture Capital | Shenzhen, China | 15 | 79 | Global Technology, Zhongke Ruijian, Xunjie Guangyuan |
| 7 | Matrix Partners China | Beijing, China | 14 | 186 | Houmo.AI, Astribot, SemiDrive |
| 8 | IDG Capital | Beijing, China | 13 | 257 | Zero Zero Robotics, XPENG Robotics, LaiHua |
| 9 | Shunwei Capital | Beijing, China | 12 | 125 | SAGE Intelligent, Hooke Instruments, Zongwei Automation |
| 10 | TusStar | Beijing, China | 11 | 33 | Zhizhen Precision, Wuwen Zhike, Qianjue Technology |
| 11 | Source Code Capital | Chaoyang, China | 10 | 98 | FAIRINO, Nutshell Therapeutics, Raysolve |
| 12 | Baidu Ventures | Beijing, China | 10 | 45 | Nutshell Therapeutics, Xihu Xinchen, RealAI |
| 13 | SDIC Venture Capital | Xicheng, China | 9 | 36 | Bangxin Semiconductor, Shengqiang Technology, Weikaier Pharmaceutical Technology |
| 14 | CICC | Beijing, China | 9 | 53 | Global Technology, AIForceTech, Etern |
| 15 | Oriental Fortune Capital | Shenzhen, China | 9 | 93 | Micronano Core, Renshuo Solar, EVAS Intelligence |
Table 3. Biotech investors in China: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Huasaiboman Medical Cell Biology | Huasaiboman Medical Cell Biology provides new cell therapy technologies and solutions as a biotechnology company. | Biotech | Qingdao Shi, China | Series B | $30.0M | 2026-11-09 | $30.0M | ASBV | 11 to 50 | 2019 |
| Tushen Zhihe | Tushen Zhihe provides artificial intelligence protein design services. | Artificial intelligence | Minhang, China | Seed | $1.4M | 2026-11-09 | $1.5M | Wuxi Capital | 11 to 50 | 2023 |
| Bangxin Semiconductor | Bangxin Semiconductor delivers cost-effective semiconductor equipment. | Hardware | Shanghai, China | Series B | $90.0M | 2026-11-05 | $90.0M | SDIC Venture Capital | 2020 | |
| Moffett AI | Moffett AI designs AI chips and provides terminal and cloud AI chip acceleration solutions. | Artificial intelligence | Los Altos, United States | Series C | $150.0M | 2026-11-03 | $322.8M | ZhenFund, Qianhai Fund of Funds | 11 to 50 | 2018 |
| Global Technology | Global Technology supplies automotive intelligent driving systems. | Hardware | Mumbai, India | Series C | $90.0M | 2026-11-03 | $153.9M | CICC, Fortune Venture Capital | 101 to 250 | 2001 |
| Zhongke Ruijian | Zhongke Ruijian provides an AI-based counterfeit detection platform for digital content security. | Artificial intelligence | Hangzhou, China | Series A | $14.0M | 2026-11-03 | $14.0M | Fortune Venture Capital | 11 to 50 | 2020 |
| Enjosim | Enjosim researches, manufactures, and sells self-delivery systems for biomacromolecule pharmaceuticals. | Biotech | Shanghai, China | Series B | $30.1M | 2026-11-02 | $30.1M | Luminous Ventures (former Lightspeed China Partners) | 51 to 100 | 2021 |
| Micronano Core | Micronano Core develops and researches AIoT chip products for intelligent IoT and advanced technology applications. | Artificial intelligence | Hangzhou, China | Series C | $150.0M | 2026-10-28 | $490.5M | Lenovo Capital and Incubator Group (LCIG), Addor Capital, Oriental Fortune Capital | 11 to 50 | 2021 |
| Elite Robots | Elite Robots manufactures automated machinery and provides robotics solutions for industrial production. | Hardware | Shanghai, China | Series D | $30.0M | 2026-10-28 | $153.8M | Lenovo Capital and Incubator Group (LCIG) | 101 to 250 | 2016 |
| Chasing Innovation | Chasing Innovation develops and manufactures submersible drone products and solutions. | Hardware | Shenzhen, China | Series C | $15.0M | 2026-10-28 | $47.8M | Shenzhen Capital Group, Yinxinggu Capital, Qianhai Fund of Funds | 51 to 100 | 2016 |
Table 4. Biotech investors in China: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 1,746 | 66% |
| Hardware | 686 | 26% |
| Artificial intelligence | 534 | 20% |
| Health care | 416 | 16% |
| Fintech | 270 | 10% |
| Biotech | 243 | 9% |
| Commerce | 226 | 9% |
| Education | 162 | 6% |
| Energy | 68 | 3% |
| Cybersecurity | 64 | 2% |
Table 5. Biotech investors in China: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 118 | 95% |
| Seed investors | 84 | 68% |
| Late stage investors | 79 | 64% |
| Venture investors | 47 | 38% |
| Private equity investors | 21 | 17% |
| Post IPO investors | 15 | 12% |
| Debt investors | 3 | 2% |
| Convertible note investors | 1 | 1% |
Table 6. Biotech investors in China by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Biotech investors in China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 8 | 7% |
| 2010s | 64 | 56% |
| 2000s | 30 | 26% |
| 1990s | 11 | 10% |
| 1970s | 1 | 1% |
Table 8. Biotech investors in China by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in China. On 16 November 2026 that is 124 investors.
- 86 rows carry an email address and 91 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 124 rows: 4 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in China are on the list?
- 124, in the file dated 16 November 2026. 112 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 86 of the 124 carry an email address in the download and 91 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 124 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 124 rows, 86 firm email addresses and 91 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 50 of the 86 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.